« Pipeline Insights »,

About 1 200 reports

Global Orphan Drug Clinical Pipeline Insight 2022

2200 pages • By PNS Pharma

Orphan Drug Clinical Pipeline Insight 2022” report gives comprehensive insight on various clinical and non-clinical aspects associated with ongoing clinical trials of 808 orphan designated drugs across the globe

2727 3000 2318
Dec 2016

Debiopharma Cancer Drugs Clinical Pipeline Insight

28 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Debiopharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Takara Bio Cancer Drugs Clinical Pipeline Insight

31 pages • By PNS Pharma

Bio - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Takaro Bio. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Cardiff University Cancer Drugs Clinical Pipeline Insight

51 pages • By PNS Pharma

University - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Cardiff University. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Hospira Cancer Drugs Clinical Pipeline Insight

33 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Hospira. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Alnylam Pharmaceuticals Cancer Drugs Clinical Pipeline Insight

37 pages • By PNS Pharma

Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alnylam. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Alphamab Cancer Drugs Clinical Pipeline Insight

18 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alphamab. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Yuhan Cancer Drugs Clinical Pipeline Insight

22 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yuhan. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Antigenics Cancer Drugs Clinical Pipeline Insight

29 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Antigenics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Karolinska Institute Cancer Drugs Clinical Pipeline Insight

33 pages • By PNS Pharma

Institute - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Karolinska Institute. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Cephalon Cancer Drugs Clinical Pipeline Insight

73 pages • By PNS Pharma

Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Cephaloan. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

545 600 464
Nov 2016

Idera Pharmaceutical Cancer Drugs Clinical Pipeline Insight

35 pages • By PNS Pharma

Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Idera Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Agenus - Cancer Drugs Clinical Pipeline Insight

30 pages • By PNS Pharma

Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Agenus. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

MGI Pharma Cancer Drugs Clinical Pipeline Insight

26 pages • By PNS Pharma

Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by MGI Pharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Ajinomoto Cancer Drugs Clinical Pipeline Insight

29 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Ajinomoto. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Dendreon Corporation Cancer Drugs Clinical Pipeline Insight

27 pages • By PNS Pharma

Corporation - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Dendreon Corporation. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Immunomedics Cancer Drugs Clinical Pipeline Insight

84 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Immunomedics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

545 600 464
Nov 2016

Arbutus Biopharma Cancer Drugs Clinical Pipeline Insight

40 pages • By PNS Pharma

Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Arbutus. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Vertex Pharmaceutical Cancer Drugs Clinical Pipeline Insight

25 pages • By PNS Pharma

Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Vertex Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Taiho Pharmaceutical-Cancer Drugs Clinical Pipeline Insight

68 pages • By PNS Pharma

Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Taiho Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Evotec AG Cancer Drugs Clinical Pipeline Insight

34 pages • By PNS Pharma

AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Evotec AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Transgene Cancer Drugs Clinical Pipeline Insight

32 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Transgene. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Introgen Therapeutics Cancer Drugs Clinical Pipeline Insight

33 pages • By PNS Pharma

Therapeutics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Introgen Therapeutics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Curis Cancer Drugs Clinical Pipeline Insight

32 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Curis. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Yakult Honsha Cancer Drugs Clinical Pipeline Insight

44 pages • By PNS Pharma

Honsha - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yakult Honsha. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

BTG Cancer Drugs Clinical Pipeline Insight

45 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by BTG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

545 600 464
Nov 2016

Morphtek Cancer Drugs Clinical Pipeline Insight

51 pages • By PNS Pharma

Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphtek. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

WILEX AG Cancer Drugs Clinical Pipeline Insight

29 pages • By PNS Pharma

AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by WILEX AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016

Nippon Kayaku Cancer Drugs Clinical Pipeline Insight

84 pages • By PNS Pharma

Kayaku - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Nippon Kayaku. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

545 600 464
Nov 2016

Celtic Pharma Cancer Drugs Clinical Pipeline Insight

51 pages • By PNS Pharma

Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Celtic Pharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline

455 500 386
Nov 2016